ZTS - Zoetis Inc.
Close
196.48
0 0%
Share volume: 0
Last Updated: Fri 20 Dec 2024 09:01:10 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.51%
PREVIOUS CLOSE
CHG
CHG%
$196.48
-32.34
0.20%
Fundamental analysis
81%
Profitability
87%
Dept financing
42%
Liquidity
75%
Performance
87%
Performance
5 Days
-6.24%
1 Month
-6.72%
3 Months
-14.85%
6 Months
-3.65%
1 Year
-15.32%
2 Year
13.75%
Key data
Stock price
$196.48
DAY RANGE
$164.14 - $196.48
52 WEEK RANGE
$149.90 - $200.53
52 WEEK CHANGE
-$15.46
DIVIDEND
$0.432
EX-DIVIDEND DATE
07/18/2024
NEXT EARNINGS DATE
10/31/2024
Company detail
CEO: Kristin C. Peck
Region: US
Website: zoetis.com
Employees: 13,800
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: zoetis.com
Employees: 13,800
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts.
Recent news